EU Medicines AgencyRT @bfarm_de: BfArM President @Karl_Broich: Our aim is to improve the way #EUclinicaltrials are regulated to better support medical research + innovation. #CTIS is an important step to simplify and expedit the application process. But we want to go further: https://t.co/0p5wgHe2VR #ICTD2022
BfArM - Blog - "Working towards a fundamental transformation of the clinical research environment"
Clinical trials are a prerequisite for medical progress. They offer patients a chance at early access to innovative therapeutic options as new treatment possibilities are introduced into medical practice. Prof. Karl Broich, President of the BfArM explains why Europe is such an important environment for clinical trials and what changes are necessary with regard to authorisation procedures.